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Previous studies in our laboratory, demonstrating the intracellular DNA modifying potential of phototherapy, have generated some concern since many chemical carcinogens, mutagens and/or teratogens derive their activity from a similar ability to modify intracellular DNA. More recent studies have suggested that the wavelength(s) with maximum genetic activity is around 450 nm. Since the absorption maximum for bilirubin, and presumably the wavelength for maximum photodecomposition is near 435 nm, it is conceivable that these two photochemical activities can be dissociated. The present study deals with the use of "sharp cut" glass filters in conjunction with phototherapy lights. It was shown that utilization of selected interference filters could dramatically decrease light-induced DNA modification in prokaryotic and eukaryotic cell lines while causing only a slight (1.5 fold) diminution in the rate of bilirubin decomposition. Since the optimal rate of bilirubin photodecomposition for the treatment of neonatal jaundice is not known, the present study demonstrates the feasibility of dissociating the beneficial therapeutic effects of phototherapy from the potentially detrimental mutagenic, carcinogenic and/or teratogenic effects. 32-34 37.5%.1 6.Rq.7 12.4'2.4 Control 11, (11) 30-34 37.0i4.2 5.9'0.5 9.4q.0 Full-tern, (11) 38-42 51,.!*3.9 9.0f0.6 10.5f1.3 In both RDS groups T3 was comparable and significantly lower than control groups, P<0.001. Tq in RnS I1 was significantlv higher than in RDS I (P<0.05) but comparable to control 11. TSt was slightlv higher in RDS I1 but there was no significant difference in any grouD. The data demonstrate: 1. a persistent prenatal abnormalitv in T3 of RDS habies, 2. normal increase in T4 concentration according to gestational age in RDS habies, 3. normal thyroid function in babies who develop non-QPS illnesr Since T3 is primarily derived from extrathvroid sources, the observation of low Tg .~nd normal Tq excludes thyroid as the primary sight of T3 deficiencv. T3 deficiencv, however, mav adverselv effect the maturation of surfactant producing enzyme apparatus. years w i t h T. P a t i e n t r e c a l l s being extremely s h o r t and s e x u a l l y i n f a n t i l e u n t i l age 20 when T was begun. Subsequently he grew t o 160 cm; developed c a n t secondary sexual c h a r a c t e r i s t i c s , normal l i b i d o and potenc) u t no sperm. His w i f e wished t o conceive. I n Jan. ' 7 6 FSH, LH
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Cord blood ampicillin levels were studied in 30 neonates ranging in gestational age from 28 to 44 wks. (988 gms to 3620 gms). Cord specimens were obtained immediately following delivery and frozen at -70°C until tested by the microbiologic discdiffusion assay. Maternal ampicillin was administered over 15 minutes as a single 2 gms IV dose in 22 patients (1 set of twins), as a single 1 gm dose in 3 pts. and as a multiple dose of 2 gms followed in 4 hrs. by 1 gm in 4 pts. Indications for ampicillin therapy and dosage remained the responsibility of the obstetrical service; 19 mothers received drug for C-section prophylaxis, 6 for PROM and 4 for amnionitis. Interval from last ampicillin dose to delivery cord blood sampling ranged fron 11 to 332 minutes (mean 84.4 mins.) and ampicillin levels ranged from 2.9 to 40 uglml (mean 18.7 uglml) . No significant differences existed between levels in the C-section prophylaxis group, PROM group and amnionitis group. The mean level was 18.6 ug/ml for the C-section prophylaxis group. The mean levels at 5 30, 5 60, 5 90, 6 120, 5 180 and >I80 minutes were 22.8 ug/ ml, 15.8 uglml, 24.8 uglml, 20.8 uglml, 11 .2 uglml and 6.2 uglml respectively. The cord ampicillin level determinations were well within the minimal inhibitory concentration (MIC) for the usual ampicillin-sensative pathogens of the newborn. No postnatal infections were noted in the 30 neonates studied.
The effect of maternal ampicillin prophylaxis on neonatal putcome must await further controlled study.
nd.GH were low; TSH, ACTH and ADH f u n c t i o n , normal. Response t o x i s shown. Hypocalcemia (serum Ca 6.5 mgI100 m l ) and hyperphosphatemia (serum P 9.5 mg1100 m l ) were observed i n a 10-day-old female i nf a n t w i t h increased neuromuscular i r r i t a b i l i t y . Hypocalcemia p e r s i s t e d u n t i l t h e s i x t h week o f l i f e and was r e s i s t a n t t o conv e n t i o n a l therapy. D u r i n g t h i s p e r i o d t h e serum P remained e l evated and t h e serum Mg was low normal t o m i l d l y depressed. I n t h e presence o f hypocalcemia, c i r c u l a t i n g immunoreactive parat h y r o i d hormone (iPTH) l e v e l s i n t h e neonate were i n a p p r o p r i a t el y low. I n c o n t r a s t t o t h e newborn i n f a n t , t h e asymptomatic mother was hypercalcemic (serum Ca 11.7-12.3 mg/100 m l ) , hypophosphatemic (serum P 1.5-2.1 mg/100 m l ) and had c o n s i s t e n t l y e l e v a t e d c i r c u l a t i n g iPTH l e v e l s . Subsequently, an adenoma was removed f r o m t h e l e f t s u p e r i o r p a r a t h y r o i d gland o f t h e mother and h e r serum Ca and iPTH l e v e l s r e t u r n e d t o normal. T h i s study i n d i c a t e s t h a t p a r a t h y r o i d f u n c t i o n was depressed i n a hypocalcemic i n f a n t born o f an asymptomatic h y p e r p a r a t h y r o i d mother.
T. S. Count L i b i d o :onclusion: Prompt t e s t o s t e r o n e s e c r e t i o n and spermatogenesis :an be induced w i t h gonadotropins i n a h y p o p i t u i t a r y male, even ~f t e r a decade o f t e s t o s t e r o n e t r e a t m e n t . Our teenage h y p o p i t u i -
T h i s f i n d i n g i s c o n s i s t e n t w i t h t h e h y p o t h e s i s t h a t i n maternal
h y p e r p a r a t h y r o i d i s m an i n c r e a s e i n maternal c i r c u l a t i n g Ca and/or p a r a t h y r o i d hormone f a c i l i t a t e s Ca t r a n s p o r t across t h e p l a c e n t a , l e a d i n g t o f e t a l hypercalcemia which, i n t u r n , suppresses p a r a t h y r o i d a c t i v i t y i n t h e f e t u s and neonate and t h e r eby promotes t h e development o f hypocalcemia i n t h e newborn p e r i o d .
